Endocrinology, Diabetes & Metabolism Doctors in Everett, WA Accepting Medicare

6 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 6

Dr. George Steven Hammond, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3407 Wave Dr, Everett, WA 98203 Phone: 425-347-6842

Isha Shrestha, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 12800 Bothell Everett Hwy Ste 250, Everett, WA 98208 Phone: 425-316-5440

Alan Wong, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-259-0966

Michael J Tamber, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-259-0966

David Liao, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1330 Rockefeller Ave, Suite 330, Everett, WA 98201 Phone: 425-259-4413

Dr. Elizabeth Hsu, MB BCH BAO Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 12728 19th Ave Se Ste 300, Everett, WA 98208 Phone: 425-420-1650    Fax: 509-633-1933

News Archive

Local variations in climate not likely to drive early COVID-19 pandemic

Local variations in climate are not likely to dominate the first wave of the COVID-19 pandemic, according to a Princeton University study published May 18 in the journal Science.

School's suspension policy can prevent students from drinking

"Just say no" has been many a parent's mantra when it comes to talking to their children about drugs or alcohol. Schools echo that with specific policies against illicit use on school grounds. But do those school policies work?

Relapse from antidepressant medication may be lack of response to medication in the first place

A new study by Rhode Island Hospital researchers indicates that a relapse during antidepressant continuation treatment may be due to a relapse in patients who were not true drug responders.

NIAID's ACTG and TB Alliance partner to complete moxifloxacin Phase III trial

The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases' (NIAID) AIDS Clinical Trial Group (ACTG) to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis (TB) treatments.

Read more Medical News

› Verified 1 days ago